Kenneth C. Cundy - 01 Jun 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Scientific Officer
Signature
/s/ Kenneth C Cundy
Issuer symbol
ANEB
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
4
Filing time
07 Jun 2022, 16:10:17 UTC
Previous filing
24 May 2022
Next filing
13 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Option to purchase Common Stock Award $0 +350,169 $0.000000 350,169 01 Jun 2022 Common Stock 350,169 $2.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Cundy received a stock option to purchase shares of the Issuer's common stock pursuant to the Issuer's 2020 Stock Incentive Plan: (a) 233,446 shares will vest in equal quarterly installments from July 1, 2022 through April 1, 2026. (b) 116,723 shares will vest upon completion of certain milestone events.